Fox Chase researchers uncover one force behind the MYC oncogene in many cancers

DLX5, a gene crucial for embryonic development, promotes cancer by activating the expression of the known oncogene, MYC, according to researchers from Fox Chase Cancer Centre. Since the DLX5 gene is inactive in normal adults, it may be an ideal target for future anti-cancer drugs, they reason. Their findings are published in the 31 July edition of the Journal of Biological Chemistry, available online now...

Read the whole article on

More from